Eddit
Aus coViki
(Unterschied zwischen Versionen)
| (40 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
__NOTOC__ | __NOTOC__ | ||
*'''[[Further reading]]''' | *'''[[Further reading]]''' | ||
| − | |||
| − | |||
| + | *'''[[Unproven ideas]]''' | ||
| + | *'''[[Reviews on covid19 disease]]''' | ||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
| − | |||
| + | *'''[[Respiration mgmt]]''' | ||
*'''[[Diagnosis (Laboratory)]]''' | *'''[[Diagnosis (Laboratory)]]''' | ||
| − | |||
| − | |||
| − | |||
| Zeile 23: | Zeile 20: | ||
| − | |||
*'''[[Structure of covid19]]''' | *'''[[Structure of covid19]]''' | ||
| + | |||
| + | |||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
| − | |||
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
*'''[[Secretion and shedding]]''' | *'''[[Secretion and shedding]]''' | ||
| Zeile 41: | Zeile 38: | ||
| − | + | ||
*'''[[Pathobiology]]''' | *'''[[Pathobiology]]''' | ||
| − | |||
| − | |||
*'''[[Disease Models]]''' | *'''[[Disease Models]]''' | ||
| − | |||
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
| + | |||
| Zeile 63: | Zeile 58: | ||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
| + | |||
| + | |||
| + | |||
| + | |||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
| Zeile 74: | Zeile 73: | ||
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
| − | |||
| − | *'''[[ | + | *'''[[Dermatology]]''' |
| + | *'''[[Gastroenterology, hepatology]]''' | ||
*'''[[Kidney, urology]]''' | *'''[[Kidney, urology]]''' | ||
| − | + | *'''[[The morbid survivor]]''' | |
*'''[[Risk and special populations]]''' | *'''[[Risk and special populations]]''' | ||
| − | + | ||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
| Zeile 94: | Zeile 93: | ||
| − | |||
| − | |||
| − | |||
| − | |||
| + | *'''[[Case series]]''' | ||
| − | *'''[[ | + | *'''[[Registries]]''' |
| + | *'''[[Trials]]''' | ||
| + | *'''[[Candidate Compounds Covid19]]''' | ||
| + | *'''[[Other routes of infection]]''' | ||
| + | *'''[[Biophysics of aerosols]]''' | ||
| + | *'''[[Passive protective equipment]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Running your hospital]]''' | *'''[[Running your hospital]]''' | ||
| Zeile 129: | Zeile 124: | ||
*'''[[Mental aspects of health professionals]]''' | *'''[[Mental aspects of health professionals]]''' | ||
| − | |||
*'''[[Socio-psychiatric aspects of the status hygienicus]]''' | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | ||
| + | |||
*'''[[Avoiding clinical medicine in other diseases]]''' | *'''[[Avoiding clinical medicine in other diseases]]''' | ||
| + | |||
| + | |||
*'''[[Occupational medicine, workplace security and status hygienicus]]''' | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | ||
| Zeile 141: | Zeile 138: | ||
*'''[[Economic aspects of the status hygienicus]]''' | *'''[[Economic aspects of the status hygienicus]]''' | ||
| − | |||
| Zeile 153: | Zeile 149: | ||
*'''[[Epidemiology]]''' | *'''[[Epidemiology]]''' | ||
| + | |||
| + | |||
*'''[[Remission, recurrence and persistence]]''' | *'''[[Remission, recurrence and persistence]]''' | ||
| + | |||
| + | |||
*'''[[Failure of executive measures]]''' | *'''[[Failure of executive measures]]''' | ||
---- | ---- | ||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
| − | |||
| Zeile 176: | Zeile 175: | ||
*'''[[History of covid19 exploration]]''' | *'''[[History of covid19 exploration]]''' | ||
| + | *'''[[misc.]]''' | ||
| + | *'''[[Research tools]]''' | ||
| − | |||
| − | + | ||
| + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} | ||
| + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} | ||
| + | |||
*'''[[PrePrint scene]]''' | *'''[[PrePrint scene]]''' | ||
| + | |||
*'''[[from the ads]]''' | *'''[[from the ads]]''' | ||
| + | |||
*'''[[Current state of coviki.org]]''' | *'''[[Current state of coviki.org]]''' | ||
*'''[[on-topic personal thoughts]]''' | *'''[[on-topic personal thoughts]]''' | ||
Aktuelle Version vom 7. Juni 2020, 22:19 Uhr
27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
25040500 2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system
